Agglutination of formalin-fixed, platelet-type von Willebrand's disease platelets by human von Willebrand factor

Thromb Haemost. 1984 Dec 29;52(3):267-70.

Abstract

The interaction of platelets and von Willebrand factor (vWF) in platelet-type von Willebrand's disease (vWD) was characterized using formalin-fixed platelets from the patients. Formalin-fixed patient platelets were agglutinated directly by human vWF in normal plasma and type IIB vWD plasma, but not in type IIA vWD plasma. In the presence of a small amount of normal vWF, ristocetin-induced agglutination of patient platelets was enhanced with low concentrations of ristocetin. Wheat germ agglutinin and EDTA inhibited vWF-induced agglutination, although EDTA had no effect on ristocetin (plus vWF)-induced agglutination. These results demonstrate that vWF-induced agglutination of platelet-type vWD platelets is independent of active platelet metabolism but requires divalent cations, and suggest that platelet membrane glycoprotein I (GPI) would be involved in this agglutination.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Blood Coagulation Factors / physiology*
  • Edetic Acid / pharmacology
  • Glycoproteins / physiology
  • Humans
  • In Vitro Techniques
  • Membrane Proteins / physiology
  • Platelet Aggregation* / drug effects
  • Platelet Membrane Glycoproteins
  • Ristocetin / pharmacology
  • von Willebrand Diseases / blood*
  • von Willebrand Factor / physiology*

Substances

  • Blood Coagulation Factors
  • Glycoproteins
  • Membrane Proteins
  • Platelet Membrane Glycoproteins
  • von Willebrand Factor
  • Ristocetin
  • Edetic Acid